Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA

Watchlist Manager
Kiniksa Pharmaceuticals Ltd Logo
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Watchlist
Price: 21.48 USD -4.43% Market Closed
Market Cap: 1.5B USD
Have any thoughts about
Kiniksa Pharmaceuticals Ltd?
Write Note

Wall Street
Price Targets

KNSA Price Targets Summary
Kiniksa Pharmaceuticals Ltd

Wall Street analysts forecast KNSA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KNSA is 34.88 USD with a low forecast of 30.3 USD and a high forecast of 42 USD.

Lowest
Price Target
30.3 USD
41% Upside
Average
Price Target
34.88 USD
62% Upside
Highest
Price Target
42 USD
96% Upside

KNSA Last Price Targets
Kiniksa Pharmaceuticals Ltd

The latest public price target was made on Oct 29, 2024 by Liisa Bayko from Evercore ISI , who expects KNSA stock to rise by 63% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Liisa Bayko
Evercore ISI
35 USD
Upside 63%
1 week ago
Oct 29, 2024
Kiniksa (KNSA) PT Raised to $35 at Evercore ISI
StreetInsider
Roger Song
Jefferies
40 USD
Upside 86%
1 month ago
Sep 13, 2024
Jefferies Starts Kiniksa (KNSA) at Buy
StreetInsider
Eva Fortea Verdejo
Wells Fargo
34 USD
Upside 58%
6 months ago
May 3, 2024
Wells Fargo Starts Kiniksa (KNSA) at Overweight, 'we see +15-25% upside potential'
StreetInsider
Liisa Bayko
Evercore ISI
Price Target 35 USD
Upside/Downside 63%
View Source
Roger Song
Jefferies
Price Target 40 USD
Upside/Downside 86%
View Source
Eva Fortea Verdejo
Wells Fargo
Price Target 34 USD
Upside/Downside 58%
View Source
Kiniksa Pharmaceuticals Ltd Competitors:
Price Targets
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
18% Upside
9926
Akeso Inc
2% Upside
PRQR
ProQR Therapeutics NV
20% Upside
CUV
Clinuvel Pharmaceuticals Ltd
104% Upside
TWST
Twist Bioscience Corp
29% Upside
NTLA
Intellia Therapeutics Inc
355% Upside
ASND
Ascendis Pharma A/S
61% Upside
EXEL
Exelixis Inc
11% Downside

Revenue
Forecast

Revenue Estimate
Kiniksa Pharmaceuticals Ltd

The compound annual growth rate of Kiniksa Pharmaceuticals Ltd's revenue for the next 3 years is 37%.

N/A
Past Growth
37%
Estimated Growth
Estimates Accuracy
3%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Kiniksa Pharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

Net Income
Forecast

Net Income Estimate
Kiniksa Pharmaceuticals Ltd

The compound annual growth rate of Kiniksa Pharmaceuticals Ltd's net income for the next 3 years is 56%.

N/A
Past Growth
56%
Estimated Growth
Estimates Accuracy
-9%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KNSA's stock price target?
Price Target
34.88 USD

According to Wall Street analysts, the average 1-year price target for KNSA is 34.88 USD with a low forecast of 30.3 USD and a high forecast of 42 USD.

What is Kiniksa Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
37%

The compound annual growth rate of Kiniksa Pharmaceuticals Ltd's revenue for the next 3 years is 37%.

What is Kiniksa Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
56%

The compound annual growth rate of Kiniksa Pharmaceuticals Ltd's net income for the next 3 years is 56%.

Back to Top